Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

被引:391
作者
Thijssen, Victor L. J. L.
Postel, Ruben
Brandwijk, Ricardo J. M. G. E.
Dings, Ruud P. M.
Nesmelova, Irina
Satijn, Sietske
Verhofstad, Nicole
Nakabeppu, Yusaku
Baum, Linda G.
Bakkers, Jeroen
Mayo, Kevin H.
Poirier, Francoise
Griffioen, Arjan W. [1 ]
机构
[1] Univ Maastricht, Angiogenesis Lab, GROW, Dept Pathol, NL-6202 AZ Maastricht, Netherlands
[2] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands
[3] Interuniv Cardiol Inst Netherlands, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands
[4] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
[5] Kyushu Univ, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 8128582, Japan
[6] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[7] Univ Paris 06, UMR 7592, Inst Jacques Monod, CNRS, F-75251 Paris, France
[8] Univ Paris 07, UMR 7592, Inst Jacques Monod, CNRS, F-75251 Paris, France
关键词
angiostatic therapy; endothelial cell; galectin; tumor models; anginex;
D O I
10.1073/pnas.0603883103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We describe that galectin-1 (gal-1) is a receptor for the angiogenesis inhibitor anginex, and that the protein is crucial for tumor angiogenesis. gal-1 is overexpressed in enclothelial cells of different human tumors. Expression knockdown in cultured enclothelial cells inhibits cell proliferation and migration. The importance of gal-1 in angiogenesis is illustrated in the zebrafish model, where expression knockdown results in impaired vascular guidance and growth of dysfunctional vessels. The role of gal-1 in tumor angiogenesis is demonstrated in gal-1 -null mice, in which tumor growth is markedly impaired because of insufficient tumor angiogenesis. Furthermore, tumor growth in gal-1-null mice no longer responds to antiangiogenesis treatment by anginex. Thus, gal-1 regulates tumor angiogenesis and is a target for angiostatic cancer therapy.
引用
收藏
页码:15975 / 15980
页数:6
相关论文
共 48 条
[1]   Biochemical and molecular characterization of galectins from zebrafish (Danio rerio):: notochord-specific expression of a prototype galectin during early embryogenesis [J].
Ahmed, H ;
Du, SJ ;
O'Leary, N ;
Vasta, GR .
GLYCOBIOLOGY, 2004, 14 (03) :219-232
[2]   Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature [J].
Åkerman, ME ;
Pilch, J ;
Peters, D ;
Ruoslahti, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :2040-2045
[3]   ROLE OF GALAPTIN IN OVARIAN-CARCINOMA ADHESION TO EXTRACELLULAR-MATRIX INVITRO [J].
ALLEN, HJ ;
SUCATO, D ;
WOYNAROWSKA, B ;
GOTTSTINE, S ;
SHARMA, A ;
BERNACKI, RJ .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1990, 43 (01) :43-57
[4]   GALECTINS - A FAMILY OF ANIMAL BETA-GALACTOSIDE-BINDING LECTINS [J].
BARONDES, SH ;
CASTRONOVO, V ;
COOPER, DNW ;
CUMMINGS, RD ;
DRICKAMER, K ;
FEIZI, T ;
GITT, MA ;
HIRABAYASHI, J ;
HUGHES, C ;
KASAI, K ;
LEFFLER, H ;
LIU, FT ;
LOTAN, R ;
MERCURIO, AM ;
MONSIGNY, M ;
PILLAI, S ;
POIRER, F ;
RAZ, A ;
RIGBY, PWJ ;
RINI, JM ;
WANG, JL .
CELL, 1994, 76 (04) :597-598
[5]   Cloning an artificial gene encoding angiostatic anginex: From designed peptide to functional recombinant protein [J].
Brandwijk, RJMGE ;
Nesmelova, I ;
Dings, RPM ;
Mayo, KH ;
Thijssen, VLJL ;
Griffioen, AW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (04) :1261-1268
[6]   Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion [J].
Clausse N. ;
Van Den Brûle F. ;
Waltregny D. ;
Garnier F. ;
Castronovo V. .
Angiogenesis, 1999, 3 (4) :317-325
[7]   Galectinomics: finding themes in complexity [J].
Cooper, DNW .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2002, 1572 (2-3) :209-231
[8]   Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer [J].
De Lussanet, QG ;
Backes, WH ;
Griffioen, AW ;
Padhani, AR ;
Baeten, CI ;
Van Baardwijk, A ;
Lambin, P ;
Beets, GL ;
Van Engelshoven, JMA ;
Beets-Tan, RGH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (05) :1309-1315
[9]  
Dings RPM, 2003, CANCER RES, V63, P382
[10]   Anti-tumor activity of the novel angiogenesis inhibitor anginex [J].
Dings, RPM ;
van der Schaft, DWJ ;
Hargittai, B ;
Haseman, J ;
Griffioen, AW ;
Mayo, KH .
CANCER LETTERS, 2003, 194 (01) :55-66